![](/img/cover-not-exists.png)
A phase II, multicenter, single-arm trial of eribulin as first-line chemotherapy for HER2-negative locally advanced or metastatic breast cancer
Takashima, Tsutomu, Tokunaga, Shinya, Tei, Seika, Nishimura, Shigehiko, Kawajiri, Hidemi, Kashiwagi, Shinichiro, Yamagata, Shigehito, Noda, Satoru, Nishimori, Takeo, Mizuyama, Yoko, Sunami, Takeshi, TVolume:
5
Language:
english
Journal:
SpringerPlus
DOI:
10.1186/s40064-016-1833-1
Date:
December, 2016
File:
PDF, 900 KB
english, 2016